Merck spends $10 billion for Verona, gaining access to its COPD medication
Read full article: Merck spends $10 billion for Verona, gaining access to its COPD medicationPharmaceutical giant Merck is buying Verona Pharma, a company that concentrates its efforts on respiratory diseases, in an approximately $10 billion deal.
:strip_exif(true):strip_icc(true):no_upscale(true):quality(65)/d1vhqlrjc8h82r.cloudfront.net/02-18-2021/t_e9e050f5259d4305b6fefa6dfc84425d_name_image.jpg)